While securing data is a concern, deciding the most applicable and cost-efficient technology is the most important priority for health organizations.
The buy versus build methodology has morphed into more of a buy-and-build process. This is due to the scope and complexity of launching purchased software that must meet the requirements for rapidly changing rules and regulations, driving patient satisfaction and improving bottom line financial performance.
The long-term impact on a provider’s organization warrants careful consideration so that technology decisions are made with the strategy that ultimately will have the most positive effect on the entire enterprise. While it takes substantial time and effort from technology leaders and stakeholders to make the most appropriate decision buy, build or both, the costs of making a poor decision can be catastrophic. On the other hand, the benefits of making the right decision can positively affect a hospital’s bottom line for decades to come.
Phil C. Solomon is the Vice President of Global Services for MiraMed, a global healthcare revenue cycle outsourcing company, and is the publisher of Revenue Cycle News, a healthcare business information blog. Phil has over 25 years’ experience consulting on a broad range of healthcare initiatives for clinical and revenue cycle performance improvement. He has worked with the industry’s largest health systems, developing executable strategies for revenue enhancement, expense reduction and clinical transformation. He can be reached at phil.solomon@miramedgs.com, (404) 849-8065 and also on Twitter @philcsolomon.
Thank You!
Download White PaperMore Program Information
